Bajaj Healthcare Appoints Sandeep Shah as Additional Non-Executive Director
Bajaj Healthcare's Board of Directors has appointed Sandeep Shah as an Additional Director in the Non-Executive Non-Independent category, effective August 18, 2025. Shah, a commerce graduate with over 23 years of experience in Registrar and Share Transfer services, has worked with organizations like Karvy Consultants Private Limited and Par Computer Sciences (International) Limited. He also has more than 16 years of experience in Company Secretarial work with a PCS firm. The appointment is subject to shareholder approval.
Bajaj Healthcare Limited reported impressive Q1 financial results with revenue from operations increasing by 12.5% year-on-year to ₹148.84 crore. The company's API export business surged by 68.4%, while the formulations segment grew by 41.1%. Profit for the period rose by 65.9% to ₹11.83 crore. The company received new regulatory approvals, advanced its CDMO operations, and made progress in pipeline development. Bajaj Healthcare's export contribution increased to 35% of total revenue, up from 23% in the same quarter last year.
28Jul 25
Bajaj Healthcare Reports 66% Surge in Q1 Net Profit Amid Revenue Growth
Bajaj Healthcare announced its Q1 FY2026 results, reporting a 66% increase in net profit to ₹118.00 crore. Revenue grew by 12.6% to ₹1,488.00 crore. However, EBITDA remained flat at ₹245.00 crore, with margins compressing to 16.47% from 18.53% year-over-year. The Board of Directors approved these unaudited standalone financial results on July 28, 2025, after a review by statutory auditors Walker Chandiok & Co. LLP.
27May 25
Bajaj Healthcare Swings to Profit in Q4, Announces Dividend
Bajaj Healthcare Ltd. reported a significant turnaround in Q4, posting a net profit of ₹111.80 crore compared to a loss of ₹299.20 crore in the previous year. Revenue increased to ₹154.00 crore, up 14.93% year-over-year. The company's board recommended a final dividend of ₹1.00 per equity share. Despite the strong yearly recovery, there was a slight decrease in profit from ₹117.20 crore in the previous quarter.
26May 25
Bajaj Healthcare Reports Q4 Profit Turnaround and Announces Dividend
Bajaj Healthcare Limited's Q4 results show a significant improvement, with revenue increasing by 14.93% to ₹154.00 crore. The company returned to profitability with a net profit of ₹11.18 crore, compared to a loss of ₹29.92 crore in the same quarter last year. Despite EBITDA declining to ₹11.76 crore and margins contracting to 7.61%, the board recommended a final dividend of ₹1.00 per equity share.
10Apr 25
Bajaj Healthcare Strengthens Financial Leadership with Appointment of Rohan Parekh as CFO
Bajaj Healthcare Limited has appointed Mr. Rohan Parekh as the new Chief Financial Officer (CFO) and Key Managerial Personnel, effective April 16, 2025. Mr. Parekh, a qualified chartered accountant with over 13 years of experience, brings expertise in corporate strategy, financial planning, and treasury management. Additionally, the company has granted 2,500 stock options to employees under its 2024 ESOP plan, with an exercise price of Rs. 5.00 per option.
Bajaj Healthcare Expands Manufacturing Capabilities with ₹10.85 Crore Acquisition of Genrx Pharmaceuticals
Bajaj Healthcare Limited (BHL) has acquired Genrx Pharmaceuticals Private Limited for ₹10.85 crore in cash, gaining 100% control. Genrx, a WHO-GMP certified manufacturer, specializes in allopathic formulations, nutraceuticals, and natural products. The acquisition expands BHL's manufacturing portfolio, strengthening its position in the pharmaceutical sector. The deal is expected to close in 3-6 months, pending regulatory approvals.
03Apr 25
Bajaj Healthcare CFO Dayashankar Patel Resigns, Effective April 15
Bajaj Healthcare Limited (BHL) announced the resignation of CFO Dayashankar Patel, effective April 15, 2025, citing personal reasons. The company appreciated his services and confirmed no material reasons for the resignation beyond those stated. The announcement complies with SEBI regulations, and BHL is expected to manage the transition in financial leadership.
02Apr 25
Bajaj Healthcare CFO Dayashankar Patel Steps Down, Citing Personal Reasons
Bajaj Healthcare Limited announced that its Chief Financial Officer (CFO), Dayashankar Patel, has resigned due to personal reasons. Patel will be relieved from his duties as CFO and Key Managerial Personnel after April 15, 2025. The company expressed appreciation for Patel's services and confirmed no material reasons for the resignation beyond those stated. The announcement was made on April 2, 2025, allowing for a brief transition period. Bajaj Healthcare has complied with SEBI regulations by disclosing the change to relevant stock exchanges. No successor has been announced yet.